Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 91
Filter
3.
Paraguay Oral Research ; 8(1): 47-54, julio 2019.
Article in Spanish | LILACS, BDNPAR | ID: biblio-1021725

ABSTRACT

El hemangioma, según la Organización Mundial de la Salud (OMS), es una neoplasia vascular benigna, caracterizada por la proliferación anormal de vasos sanguíneos, se presenta como una lesión única, pudiéndose observar en cualquier parte del organismo, sin embargo es más incidente en el área de cabeza y cuello, con predominio en los labios, en la lengua y en la mucosa yugal. Técnicamente, su exrpación quirúrgica es dicil y desafiante, al estar cargada con complicaciones como hemorragia, escisión incompleta, desfiguración facial y recurrencia. Objevo: relatar el caso clínico de un paciente con hemangioma lingual tratado con Polidocanol al 0,5%. Se necesitaron de 4 sesiones de aplicación del agente esclerosaste para que retrocediera completamente la lesión donde en cada infiltración se ulizó 1ml y en la úlma sesión 0.7 ml, logrando en esta úlma obtener la desaparición de la lesión por lo que el pronósco fue bueno. Conclusión: De acuerdo a los resultados de este trabajo el uso del Polidocanol al 0.5% en tratamientos de hemangioma linguales resulta ser una técnica bastante efecva, ya que con su prácca nos da una disminución del volumen de dicha lesión


The hemangioma, according to theWorldHealthOrganizaon (WHO), is a benign vascular neoplasm, characterized by the abnormal proliferaon of blood vessels, it presents as a single lesion, it can be found anywhere in the body, however it is more incident in thearea of the head and neck, predominantlyonthelips, onthetongue and onthejugal mucosa. Technically, its surgical removal is difficult and challenging, incomplete disease, facial disfigurement and recurrence. Objecve: to report the clinical case of a paentwith lingual hemangioma treatedwith 0.5% Polidocanol. iook 4 sessions of applicaon of thesclerosingagent to completelyretrachelesionwhere 1 ml wasused in eachinfiltraon and 0.7 ml in thelastsession, obtainingthedisappear of thelesion in thelaer, so the prognosis wasgood. Conclusion: According to the results of this study, the use of Polidocanol at 0.5% in lingual hemangioma treatmentsis a very effecve technique, and with its pracce we have a decrease in the volume of this lesion


Subject(s)
Humans , Female , Middle Aged , Sclerosing Solutions/therapeutic use , Tongue Neoplasms/drug therapy , /therapeutic use , Hemangioma/drug therapy , Sclerosing Solutions/administration & dosage , /administration & dosage
4.
J. vasc. bras ; 17(4): 333-336, out.-dez. 2018. ilus
Article in Portuguese | LILACS | ID: biblio-969174

ABSTRACT

Cerebral ischemia is a very rare and harmful complication of ultrasound-guided foam sclerotherapy for treatment of varicose veins. This case describes a documented cerebrovascular ischemia in Broca's area following ultrasound-guided foam sclerotherapy. Less than one hour after intravenous injection of 10 ml of sclerosing foam, an otherwise healthy woman experienced aphasia without any other signs of neurological changes. When she arrived home, a complete inability to talk was observed. The event was misdiagnosed by another doctor as an allergic reaction. Next morning she came to the office to report the allergic reaction, where an appropriate diagnosis was made. She recovered just two days after the injection, but signs of recent cerebral ischemia were seen in Broca's area on magnetic resonance and transesophageal bubble study echocardiogram revealed a patent foramen ovale. Although rare, we must make great effort to prevent these events instead of treating them


A isquemia cerebral é uma complicação muito rara e perigosa da escleroterapia com espuma guiada por ultrassom no tratamento de varizes. Este caso descreve uma isquemia cerebral da área de Broca após escleroterapia com espuma guiada por ultrassom. Menos de uma hora após injeção de 10 mL de espuma, uma até então saudável mulher apresentou afasia, sem quaisquer outros sinais neurológicos. No caminho para casa, uma completa incapacidade de fala foi observada. Levada ao hospital mais próximo, foi diagnosticada com reação alérgica. Na manhã seguinte, compareceu ao consultório para relatar a reação alérgica, quando um correto diagnóstico foi feito. Ela ficou recuperada dois dias depois do procedimento, mas uma ressonância magnética mostrou sinais de isquemia recente da área de Broca e um ecocardiograma transesofágico mostrou um forame oval patente. Embora raros, devemos concentrar nossos esforços em prevenir tais eventos para que não precisem de tratamento


Subject(s)
Humans , Female , Ultrasonics/methods , Sclerotherapy , Brain Ischemia/complications , Sclerosing Solutions/therapeutic use , Varicose Veins/therapy , Magnetic Resonance Spectroscopy/methods , Echocardiography, Transesophageal/methods , Embolism/complications , Foramen Ovale, Patent
5.
J. vasc. bras ; 17(4): 341-347, out.-dez. 2018. ilus
Article in Portuguese | LILACS | ID: biblio-969241

ABSTRACT

A escleroterapia continua sendo um dos procedimentos mais executados pelos cirurgiões vasculares brasileiros. O conhecimento das suas complicações é imprescindível para que possamos evitá-las. Os efeitos colaterais graves desse método de tratamento para as telangiectasias dos membros inferiores são raros e frequentemente associados a um erro técnico ou à dosagem injetada. São predominantemente locais, apresentando-se, algumas vezes, como uma situação de difícil resolução. Relatamos um caso de formação de necrose cutânea após escleroterapia química com glicose hipertônica (75%) e sua cicatrização utilizando preparação tópica contendo vaselina e glicose 60%, cujo resultado estético foi satisfatório


Sclerotherapy remains one of the procedures most frequently performed by Brazilian vascular surgeons. Knowledge of its complications is indispensable to enable us to avoid them. The severe side effects of this method of treatment for telangiectasias of the lower limbs are rare and are often associated with technical errors or the dose injected. Complications are predominantly local, but are sometimes difficult to resolve. We report a case of formation of cutaneous necrosis after chemical sclerotherapy using hypertonic glucose (75%), which healed when treated with a topical preparation containing vaseline and 60% glucose, with satisfactory esthetic results


Subject(s)
Humans , Female , Middle Aged , Telangiectasis/diagnosis , Glucose , Necrosis/complications , Petrolatum/therapeutic use , Sclerosing Solutions/therapeutic use , Skin Ulcer/diagnosis , Skin Ulcer/therapy , Varicose Veins/therapy , Wound Healing , Fibrosis , Sclerotherapy/methods , Echocardiography, Doppler, Color/methods , Lower Extremity , Erythema
6.
ImplantNewsPerio ; 3(3): 518-526, mai.-jun. 2018. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-905519

ABSTRACT

O hemangioma é considerado como uma neoplasia vascular benigna, caracterizado por uma fase de crescimento rápido, com proliferação de células endoteliais, seguida por uma estabilização gradual. A principal queixa dos pacientes portadores dessa neoplasia é referente à estética e, por esse motivo, a escleroterapia vem sendo uma boa opção de tratamento para obter resultados estéticos satisfatórios. Para esse tipo de tratamento, são utilizadas aplicações com oleato de monoetanolamina a 0,05 g/ml (Ethamolin), que promovem a regressão da lesão por fibrose dos espaços endoteliais. No presente artigo, é descrito um relato de caso clínico de uma paciente do sexo feminino, portadora de um hemangioma no lábio superior esquerdo. Foram realizadas três aplicações do agente esclerosante Ethamolin no interior do tumor, até que ele regredisse o suficiente para ser removido cirurgicamente com maior segurança e eficiência. As aplicações com oleato de monoetanolamina proporcionaram a involução do hemangioma de forma rápida e segura, de modo a promover uma esclerose dos vasos tumorais, favorecendo a remoção cirúrgica.


The hemangioma is considered as a benign vascular neoplasm, characterized by a phase of rapid growth, with proliferation of endothelial cells, followed by gradual estabilization. The main complaint of patients with this neoplasm is related to aesthetics and, for this reason, sclerotherapy has been a good treatment option to obtain satisfactory aesthetic results. For this type of treatment, applications with 0.05 g/ml Monoethanolamine Oleate (Ethamolin), which causes regression of the lesion by fibrosis of the endothelial spaces, are used. In the present article a clinical case report of a female patient with a hemangioma in the upper left lip will be described. As a treatment, three applications of the Ethamolin sclerosing agent were performed inside the tumor until it regress to be excised with greater safety and efficiency. The applications with Monoethanolamine Oleate provided a quick hemangioma involution, in order to promote sclerosis of tumor vessels, favoring it surgical removal.


Subject(s)
Humans , Female , Middle Aged , Hemangioma/therapy , Lip Neoplasms/therapy , Oleic Acid/therapeutic use , Oral Surgical Procedures , Sclerosing Solutions/therapeutic use , Sclerotherapy , Vascular Malformations/drug therapy
7.
Rev. Col. Bras. Cir ; 44(3): 308-313, mai.-jun. 2017. tab, graf
Article in Portuguese | LILACS | ID: biblio-896583

ABSTRACT

RESUMO A termoablação endovascular das veias safenas insuficientes com laser é descrita como uma técnica menos invasiva, com resultados semelhantes à cirurgia convencional, porém, com efeitos adversos menos frequentes. A técnica de escleroterapia com espuma de polidocanol ecoguiada vem sendo empregada com a mesma finalidade. A combinação de técnicas pode representar uma alternativa para pacientes mais graves, como os portadores de úlcera varicosa. Um equipamento de laser (denominado VELAS) foi desenvolvido no Centro de Pesquisas em Ótica e Fotônica da USP-São Carlos em convênio com a FMB-UNESP para termoablação endoluminal da veia safena insuficiente. Neste estudo apresentamos os resultados preliminares do uso do aparelho de laser VELAS (diodo MMO 980nm) na termoablação endovascular de veias safenas insuficientes, em portadores de úlcera venosa crônica, associado à complementação com espuma de polidocanol para o tratamento de varicosidades, após uma semana. Os desfechos analisados foram o tempo de cicatrização da úlcera venosa, oclusão das veias tratadas e eventos adversos relacionados aos tratamentos. Foram incluídos 12 pacientes portadores de insuficiência de veia safena e úlcera venosa crônica que aceitaram participar do projeto. Todos foram tratados em regime ambulatorial, com anestesia local e termoablação da veia safena insuficiente (VELAS). Após uma semana da cirurgia, as varicosidades foram esclerosadas com polidocanol espuma (técnica de Tessari). O equipamento laser VELAS nacional apresentou fácil manuseio, oclusão venosa total em 83,3% dos pacientes (em sete dias) e a associação das técnicas foi responsável por uma taxa de cicatrização de feridas de 83,3%, sem ocorrência de eventos adversos.


ABSTRACT The endovenous laser ablation (EVLA) of the insufficient saphenous vein has similar results to open conventional surgery, but less morbidity. The echo-guided polidocanol foam sclerotherapy technique has been used for the same purpose. The combined techniques may play a role for more severe diseases, such as those with varicose ulcers. An EVLA device (called VELAS) has been developed in the Optics and Photonics Research Center of USP-São Carlos in agreement with FMB-UNESP. In this study, we present the preliminary results of the VELAS device (MMO 980nm diode) in patients with chronic venous ulcer, associated with echo-guided polidocanol foam sclerotherapy for the treatment of varicosities. Primary outcomes were healing time of the venous ulcer, occlusion of the treated veins and treatment-related adverse events. We included 12 patients with insufficient saphenous vein and chronic venous ulcer. Initially, we treated all of them with thermoablation of the insufficient saphenous vein (VELAS), on an outpatient basis, with local anesthesia. After one week of the procedure, we sclerosed the varicosities with polidocanol foam (Tessari technique). The national VELAS device was easily handled. Total venous occlusion occurred in 83.3% of the patients (in seven days) and the association of the techniques was responsible for a wound healing rate of 83.3%, with no adverse events.


Subject(s)
Humans , Male , Female , Adult , Aged , Polyethylene Glycols/therapeutic use , Saphenous Vein , Sclerosing Solutions/therapeutic use , Venous Insufficiency/therapy , Sclerotherapy , Laser Therapy , Lasers, Semiconductor/therapeutic use , Endovascular Procedures/methods , Severity of Illness Index , Brazil , Treatment Outcome , Combined Modality Therapy , Polidocanol , Middle Aged
8.
J. vasc. bras ; 14(2): 145-152, Apr.-June 2015. tab, ilus
Article in English | LILACS | ID: lil-756464

ABSTRACT

BACKGROUND: Ultrasound-guided foam sclerotherapy plays a major role in treatment of chronic venous insufficiency, providing clinical and hemodynamic improvement to patients undergoing treatment.OBJECTIVES: To examine the relationships between venous refilling time and impact of venous disease on quality of life and between changes in venous refilling time and improvement of symptoms after ultrasound-guided foam sclerotherapy for chronic venous insufficiency. METHODS: Thirty-two patients classified as C4, C5 or C6 answered a questionnaire on quality of life and symptoms and their venous filling time was measured using photoplethysmography before and 45 days after treatment of chronic venous insufficiency with ultrasound-guided foam sclerotherapy.RESULTS: Statistically significant improvements were observed in quality of life scores and in venous filling time and in the following symptoms: aching, heavy legs, restless legs, swelling, burning sensations, and throbbing (p<0.0001). A similar improvement was also seen in the work and social domains of quality of life (p<0.0001).CONCLUSIONS: As confirmed by questionnaire scores and venous refilling times, ultrasound-guided foam sclerotherapy demonstrated efficacy and resulted in high satisfaction levels and low rates of major complications.


CONTEXTO: A escleroterapia com espuma guiada por ultrassom (EGUS) ocupa lugar de destaque no tratamento da insuficiência venosa crônica (IVC), proporcionando melhora clínica e hemodinâmica aos pacientes submetidos ao tratamento.OBJETIVOS: Verificar a correlação entre dados obtidos por questionário de qualidade de vida e de sintomas com dados obtidos por fotopletismografia (FPG), antes e depois do tratamento por escleroterapia com espuma guiada por ultrassom (EGUS) da insuficiência venosa crônica (IVC). MÉTODOS: Um grupo de 32 pacientes, classificados como C4, C5 e C6, foi submetido à aplicação de questionário de qualidade de vida e sintomas, sendo aferido o tempo de enchimento venoso (TEV) por FPG antes e 45 dias depois do tratamento da IVC através de EGUS. O teste do sinal foi utilizado para análise estatística da melhora dos escores dos questionários e do TEV. O teste de McNemar foi utilizado para avaliação da melhora nos sintomas e do impacto do tratamento nas atividades laborais e sociais dos pacientes.RESULTADOS: Houve melhora nos escores dos questionários de qualidade de vida e no TEV, com significância estatística (p<0,0001). Houve melhora estatisticamente significativa nos sintomas: dor, cansaço, edema, queimação, pernas inquietas e latejamento (p<0,0001). Incremento na qualidade laboral e social após o tratamento apresentou melhora estatisticamente significativa (p<0,0001). Não ocorreram complicações maiores ou efeitos adversos nesta série.CONCLUSÕES: A EGUS mostrou-se eficaz, com alto índice de satisfação e baixas taxas de complicacões maiores, ratificada pelos escores dos questionários e pelos TEVs aferidos pela FPG.


Subject(s)
Humans , Male , Female , Middle Aged , Sclerotherapy/methods , Photoplethysmography/methods , Venous Insufficiency/therapy , Quality of Life , Lower Extremity , Surveys and Questionnaires , Statistical Analysis , Sclerosing Solutions/therapeutic use , Ultrasonography, Doppler, Color/methods , Varicose Veins
9.
Clinics ; 69(8): 505-508, 8/2014. tab
Article in English | LILACS | ID: lil-718186

ABSTRACT

OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient. .


Subject(s)
Child, Preschool , Female , Humans , Infant , Male , Bleomycin/therapeutic use , Head and Neck Neoplasms/therapy , Lymphangioma, Cystic/therapy , Picibanil/therapeutic use , Punctures/methods , Sclerosing Solutions/therapeutic use , Brazil , Cross-Sectional Studies , Combined Modality Therapy/methods , Follow-Up Studies , Injections, Intralesional , Remission Induction , Retrospective Studies , Sclerosing Solutions/administration & dosage , Treatment Outcome
10.
Rev. cuba. cir ; 53(2): 167-175, abr.-jun. 2014.
Article in Spanish | LILACS | ID: lil-740895

ABSTRACT

Introducción: el tratamiento del derrame pleural maligno constituye un reto para los cirujanos. Su erradicación permanente ha constituido un largo bregar, y para ello se ha utilizado un numeroso grupo de sustancias. Objetivo: mostrar los resultados del uso de diferentes sustancias químicas para conseguir la fusión de las pleuras en el derrame pleural maligno. Métodos: fueron estudiados 116 pacientes con derrames malignos de pleura tratados mediante toracocentesis y escleroterapia química en el Hospital Universitario Comandante Manuel Fajardo entre enero de 2001 y el 2013. El diagnóstico del 100 por ciento de los pacientes fue clínico e imaginológico, con estudio del líquido pleural. Después de la toma de muestra se evacuó todo el contenido mediante un catéter colector y la instilación de la solución esclerosante. Como agentes irritantes se utilizó bleomicina, tetraciclina, amoxicilina y povidona yodada. Resultados: la causa más frecuente de derrame pleural resultó ser el cáncer de mama, seguido por el de pulmón y el ovario. En el hombre fue más frecuente el cáncer de pulmón y en la mujer el cáncer de mama. Predominó el sexo femenino y, específicamente, la sexta década de la vida. El 52,4 por ciento de los pacientes necesitó dos sesiones terapéuticas y el 15,6 por ciento no presentó recidiva después de la primera sesión. Conclusiones: los resultados fueron similares con todas las sustancias utilizadas. La intervención paliativa logró mejorar la calidad de vida al aliviar los síntomas de los pacientes y disminuir la hospitalización(AU)


Introduction: the treatment of the malignant pleural effusion poses a challenge for the surgeons, its permanent eradication has been a long struggle based on the use of a number of substances. Objective: To show the results of the use of different chemical substances to fuse the pleuras in malignant pleural effusion. Methods: one hundred and sixteen patients with malignant pleural effusions, who were treated with thoracentesis and chemical sclerotherapy at Comandante Manuel Fajardo university hospital from January 2001 through January 2013, participated in the study. Their diagnosis was based on clinical examination and imaging, with additional pleural fluid study. After the sample-taking, a collecting catheter and an instilled sclerosing solution were used to remove the whole pleural content, whereas bleomycin, tetracycline, amoxicillin and povidone iodine acted as irritating agents. Results: the most frequent cause of pleural effusion was breast cancer, followed by lung and ovary cancers. The lung cancer was commonest in men and breast cancer in females. Females and the age of 60 years prevailed. In this group, 52.4 por ciento required two therapeutic sessions and 15.6 por ciento showed no relapse after the first session. Conclusions: the results were similar with all the used substances. The palliative intervention succeeded in improving the quality of life, releasing symptoms and reducing hospitalization(AU)


Subject(s)
Humans , Male , Female , Pleural Effusion, Malignant/drug therapy , Sclerosing Solutions/therapeutic use , Thoracoscopy/methods
11.
Einstein (Säo Paulo) ; 12(2): 181-186, Apr-Jun/2014. tab, graf
Article in English | LILACS | ID: lil-713008

ABSTRACT

Objective This retrospective study evaluated the results of sclerotherapy with low doses of ethanol for treatment of head and neck venous malformations. Methods We treated 51 patients, 37 females. Median age was 23 years. Patients were treated with percutaneous intralesional injection of alcohol every two weeks and followed up prospectively for a median period of 18 months. Most lesions affected the face and cosmetic disfigurement was the most frequent complaint. Results We performed a median of 7 sessions of sclerotherapy. Complete resolution or improvement was observed in 48 patients presented. Five cases of small skin ulceration, two cases of hyperpigmentation and two of paresthesia were documented; all of them were treated conservatively. Conclusion Percutaneous sclerotherapy with low doses of ethanol is a safe and effective treatment modality for venous malformations affecting the head and neck. .


Objetivo Estudo retrospectivo que analisou os resultados da escleroterapia, com doses baixas de etanol, realizada sob anestesia local para tratamento de malformações venosas na cabeça e pescoço. Métodos Foram tratados 51 pacientes, sendo 37 do gênero feminino. A mediana de idade foi de 23 anos. Os pacientes foram tratados com injeções alcoólicas nas lesões, por via percutânea, em sessões quinzenais, e acompanhados prospectivamente por um período mediano de 18 meses. A maioria das lesões acometia a face e a queixa principal mais frequente foi deformidade estética. Resultados Foram realizadas, em média, sete sessões de escleroterapia. Resolução completa ou melhora foi observada em 48 pacientes. Cinco pacientes apresentaram pequena úlcera cutânea, dois hiperpigmentação e dois parestesia, sendo todos tratados conservadoramente. Conclusão A escleroterapia percutânea com doses baixas de etanol é um método seguro e eficaz para tratar malformações venosas na cabeça e pescoço. .


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Young Adult , Ethanol/therapeutic use , Head/blood supply , Neck/blood supply , Sclerosing Solutions/therapeutic use , Sclerotherapy/methods , Vascular Malformations/therapy , Anesthesia, Local , Injections, Intralesional , Retrospective Studies , Treatment Outcome
12.
Indian J Dermatol Venereol Leprol ; 2013 May-Jun; 79(3): 383-388
Article in English | IMSEAR | ID: sea-147473

ABSTRACT

Background: Varicose veins and its dermatological complications like stasis dermatitis, ulcers, spontaneous bleeding are commonly seen in the dermatology clinics. Surgery has been the most often used treatment for varicose veins. Sclerotherapy refers to introduction of sclerosing solution into the varicose veins, which causes endothelial damage and subsequent fibrosis. Sclerotherapy is being practised extensively by dermatosurgeons in the west. However, there are no Indian studies which specifically evaluate the role of sclerotherapy in the management of varicose veins and its skin complications. Hence, this study aims to evaluate the efficacy of sclerotherapy in managing varicose veins and its complications. Aims: To study the safety and efficacy of sclerotherapy in the treatment of varicose veins and its dermatological complications. Methods: This is a prospective study involving 50 patients with varicose veins and its dermatological complications attending the dermatology out-patient department. The study was conducted over a period of 18 months. After thorough clinical, laboratory, and radiological evaluation, the patients were treated with sclerotherapy using Sodium Tetradecyl Sulphate of various concentrations depending on the vessel size. The patients were then followed up to look for disappearance of veins, healing of ulcers and eczema, and any complications.Results: Patients showed a good response to treatment with sclerotherapy. 70-80% of patients showed symptomatic improvement along with disappearance of veins and healing of eczema and ulcers. Most of the complications were minor, which resolved over a period of few weeks. Conclusion : Sclerotherapy is a simple, safe and effective procedure for the treatment of varicose veins and its dermatological complications. The procedure is particularly effective for smaller, early varicosities and also for residual veins after surgery. Hence we recommend more and more of our fellow dermatologists to take up this procedure, which can be an efficient tool to manage patients with varicose veins and its related complications.


Subject(s)
Adult , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Sclerosing Solutions/therapeutic use , Sclerotherapy/adverse effects , Sclerotherapy/methods , Sodium Tetradecyl Sulfate/therapeutic use , Treatment Outcome , Varicose Ulcer/etiology , Varicose Ulcer/therapy , Varicose Veins/complications , Varicose Veins/therapy
13.
Rev. ADM ; 68(5): 215-221, sept.-oct. 2011. ilus
Article in Spanish | LILACS | ID: lil-655854

ABSTRACT

Mucocele y ránula, son términos clínicos aplicados para describir un pseudoquiste asociado con extravasación mucosa en los tejidos circundantes, donde se hallen glándulas salivales menores. Estas lesiones ocurren como resultado de un trauma del conducto excretor de laglándula salival o por la obstrucción de flujo salival por otra lesión asociada, como un sialolito o un tapón bacteriano. Estas patologías se originan en una glándula salival menor y son también conocidos como fenómeno de retenciónmucosa o reacción de escape mucoso.El manejo de estas lesiones es quirúrgico en todos los casos, sin embargo, presenta algunas dificultades propias del evento, complicacionespostquirúrgicas y secuelas permanentes en el paciente; en la actualidad se ha manejado este tipo de lesiones con otro tipo de terapéutica, como escleroterapia, uso de toxina Botulínicatipo A, LASER, o el OK-432 (Picibanil), que es una mezcla de Streptococo Pyogenes del grupo A mermado en su virulencia y penicilina G en polvo liofilizado que funciona como agente esclerosante para linfangiomas y agenteantineoplásico. En este trabajo se presenta una revisión bibliográficaacerca de esta patología y una nuevaopción de tratamiento con este medicamento, sus indicaciones y contraindicaciones, así como su administración, reacciones secundarias y complicaciones durante el manejo de lesiones reactivas asociadas a las glándulas salivales menores.


Subject(s)
Humans , Mucocele/drug therapy , Picibanil/therapeutic use , Ranula/drug therapy , Sclerosing Solutions/therapeutic use , Diagnosis, Differential , Postoperative Complications
14.
Rev. gastroenterol. Perú ; 31(3): 208-215, jul.-set. 2011. ilus, tab
Article in Spanish | LIPECS, LILACS, LIPECS | ID: lil-692387

ABSTRACT

OBJETIVO: Evaluar el éxito terapéutico de la inyección de N-butil-2-cianoacrilato en el tratamiento de las várices gástricas. MATERIALES Y MÉTODOS: Estudio transversal que incluyó 33 pacientes con várices gástricas que sólo recibieron terapia endoscópica con cianoacrilato entre el 2006 al 2010. El cianoacrilato fue inyectado intravaricealmente en una dilución 1:1 con lipiodol hasta obtener la obturación de las várices. La situación terapéutica fue: Hemorragia activa, várices con estigmas de sangrado reciente y profilaxis secundaria. El éxito del tratamiento se evaluó según la hemostasia, recurrencia de sangrado y obturación. RESULTADOS: De los 33 pacientes, 3 (9.1%) fueron por hemorragia activa, 20 (60.6%) con estigmas de sangrado reciente y 10 (30.3%) como profilaxis secundaria. Las várices fueron GOV2, 17 (51.5%); IGV1, 14 (42.4%) y GOV1, 2 (6.1%). Se logró hemostasia total en 21 (91.3%) pacientes con sangrado agudo o reciente y en 2 (66.7%) de 3 sujetos con sangrado activo. En 5 (15.6%) pacientes hubo recurrencia de sangrado y 2 de ellos recibieron cianoacrilato con éxito de hemostasia. Se logró obturación en 25 (75.8%) del total de pacientes. Cuatro pacientes fallecieron, uno por fracaso del control de sangrado. La mayor severidad de clasificación Child-Pugh se relacionó con falla terapéutica (p=0.034). La complicación principal fue el sangrado post-inyección del cianoacrilato. CONCLUSIONES: Nuestros resultados favorecen el uso de cianoacrilato en el tratamiento de várices gástricas, con raras complicaciones mayores.


OBJECTIVE: To evaluate the therapeutic success of the injection of N-butyl-2-cyanoacrylate in the treatment of gastric varices. METHODS: Cross-sectional study included 33 patients with gastric varices who only received cyanoacrylate endoscopic therapy between 2006 and 2010. Intravariceally, cyanoacrylate was injected in a 1:1 dilution with lipiodol until the obliteration of varices. The therapeutic situation was: active bleeding, varices with stigmata of recent bleeding and secondary prophylaxis. Treatment success was evaluated according to hemostasis, recurrent bleeding and obliteration. RESULTS: Of the 33 patients, 3 (9.1%) were for active bleeding, 20 (60.6%) with stigmata of recent bleeding and 10 (30.3%) as secondary prophylaxis. Gastric varices were GOV2, 17 (51.5%); IGV1, 14 (42.4%); GOV1, 2 (6.1%). Hemostasis was achieved in 21 (91.3%) and in 2 (66.7%) of 3 patients with active bleeding. Five (15.6%) patients had recurrent bleeding and 2 of them used cyanoacrylate with successful hemostasis. Obliteration was achieved in 25 (75.8%). Four patients died and one for failure of control bleeding. A high severity of Child-Pugh classification was related to treatment endoscopic failure (p=0.034). The main complication was bleeding after the injection of cyanoacrylate. CONCLUSIONS: Our results support the use of cyanoacrylate in the treatment of gastric varices with few major complications.


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Enbucrilate/therapeutic use , Esophageal and Gastric Varices/therapy , Gastrointestinal Hemorrhage/therapy , Gastroscopy , Hemostasis, Endoscopic , Sclerosing Solutions/therapeutic use , Sclerotherapy , Cross-Sectional Studies , Retrospective Studies , Treatment Outcome
15.
Article in English | WPRIM | ID: wpr-172638

ABSTRACT

Duodenal varices result from retroperitoneal portosystemic shunts that usually come from the pancreaticoduodenal vein and drain into the inferior vena cava. Because they are a rare but fatal cause of gastrointestinal bleeding, a prompt hemostatic intervention is mandatory. A 62-year-old man who had a history of excessive alcohol consumption presented with massive hematemesis and melena. Emergent endoscopy revealed ruptured varices with an adhering whitish fibrin clot on the postbulbar portion of the duodenum. Abdominal computed tomography demonstrated a cirrhotic liver with venous collaterals around the duodenum and extravasated contrast in the second and third portions. The collaterals originated from the main portal vein and drained via the right renal vein into the inferior vena cava. Endoscopic injection sclerotherapy with cyanoacrylate was successful in achieving hemostasis, and resulted in the near eradication of duodenal varices at a 6-month follow-up.


Subject(s)
Cyanoacrylates/therapeutic use , Duodenal Diseases/diagnosis , Duodenum/blood supply , Endoscopy, Gastrointestinal , Gastrointestinal Hemorrhage/etiology , Humans , Male , Middle Aged , Portal Vein , Rupture , Sclerosing Solutions/therapeutic use , Sclerotherapy , Tomography, X-Ray Computed , Varicose Veins/complications
16.
Braz. dent. j ; 21(4): 370-374, 2010. ilus
Article in English | LILACS | ID: lil-562101

ABSTRACT

Hemangiomas are benign tumors of infancy and childhood, characterized by a phase of fast growth with endothelial cell proliferation, occurring in 10-12 percent of children at 1 year of age. It is known that hemangiomas of infancy are most commonly located on the head and neck region (around 60 percent of cases) and occur more frequently in the lips, tongue, and palate. Approximately 50 percent of hemangiomas have complete resolution, and 90 percent of them are resolved up to the age of 9. Complications occur in only 20 percent of the cases, the most common problem being ulceration with or without infection. The treatment depends on lesion location, size and evolution stage, and the patient's age. Surgery is usually indicated when there is no response to systemic treatments, or even for esthetic reasons, being performed as a simple excision in combination or not with plastic surgery. This paper reports a case of lip cavernous hemangioma in a 4-year-old child, who was submitted to 3 sessions of vascular sclerosis due to the size of the lesion, before undergoing simple excision of the hemangioma. Two years of postoperative clinical follow-up shows treatment success with no recurrence of the lesion.


Hemangiomas são tumores benignos da infância que se caracterizam por uma fase de crescimento rápido com proliferação de células endoteliais, ocorrendo em 10 a 12 por cento das crianças com 1 ano de idade. Sua localização mais comum é nos lábios, na língua, mucosa jugal e no palato. Aproximadamente 50 por cento dos casos de hemangioma mostram completa resolução e 90 por cento deles resolvem-se até os 9 anos de idade. As complicações ocorrem em apenas 20 por cento dos casos e o problema mais comum é a ulceração com ou sem infecção. O tratamento depende da localização, do tamanho e do estágio evolutivo da lesão, bem como da idade do paciente. A cirurgia geralmente é indicada quando não há resposta aos tratamentos sistêmicos ou por razões estéticas, podendo ser empregada sob forma de exérese simples com ou sem plástica. Este artigo apresenta um caso de hemangioma cavernoso labial em uma criança de 4 anos de idade, a qual, devido ao tamanho da lesão, foi submetida a 3 sessões de esclerose vascular seguido de exérese simples da lesão, com acompanhamento clínico de 2 anos de pós-operatório.


Subject(s)
Child, Preschool , Humans , Male , Hemangioma, Cavernous/therapy , Lip Neoplasms/therapy , Sclerosing Solutions/therapeutic use , Combined Modality Therapy , Hemangioma, Cavernous/pathology , Lip Neoplasms/pathology , Treatment Outcome
17.
Clinics ; 65(9): 837-840, 2010. ilus, tab
Article in English | LILACS | ID: lil-562824

ABSTRACT

INTRODUCTION: Venous malformations are the most frequent vascular malformation. Deep venous malformations are located in subcutaneous tissue or in the muscles. Percutaneous sclerotherapy is the treatment of choice, and the use of ethanol at low doses has not yet been described. OBJECTIVE: To analyze the results of treating Deep venous malformations patients with low doses of ethanol. METHODS: Thirty-nine patients treated between July 1995 and June 2007 were followed up prospectively over a median period of 18 months. Twenty-nine were female (74.4 percent) and 10 were male (25.6 percent), with ages ranging from 11 to 59 years (median of 24 years). All of the lesions affected limbs, and the main symptom reported was pain (97.4 percent). Each patient underwent fortnightly alcohol application sessions under local anesthesia on an outpatient basis. The lesions were classified into three groups according to size using nuclear magnetic resonance imaging: small, up to 3 cm (4 patients); medium, between 3 and 15 cm (27 patients); and large, greater than 15 cm (8 patients). RESULTS: The symptoms completely disappeared in 14 patients (35.9 percent) and improved in 24 (61.5 percent). The lesion size reduced to zero in 6 patients (15.4 percent) and decreased in 32 (82 percent). The median number of sessions was 7. There were no complications in 32 patients (82 percent), while 3 presented local paresthesia (7.7 percent), 2 superficial trombophlebites (5.1 percent), 1 skin ulcer (2.6 percent), and 1 case of hyperpigmentation (2.6 percent). CONCLUSION: Outpatient treatment for Deep venous malformations patients using ethanol at low doses was effective, with a low complication rate.


Subject(s)
Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Young Adult , Ethanol/therapeutic use , Sclerosing Solutions/therapeutic use , Vascular Malformations/therapy , Anesthesia, Local , Follow-Up Studies , Magnetic Resonance Spectroscopy , Prospective Studies , Severity of Illness Index , Sclerotherapy/methods , Treatment Outcome , Young Adult
18.
Rev. cuba. invest. bioméd ; 27(2)abr.-jun. 2008. tab
Article in Spanish | LILACS | ID: lil-506273

ABSTRACT

Objetivos: documentar los resultados de los primeros 285 pacientes tratados con esclerosis con polidocanol, en forma de espuma y sin el empleo de ultrasonido como guía, por presentar várices de miembros inferiores. Métodos: Se realizó un estudio prospectivo, monocéntrico y controlado que incluyó los primeros 285 pacientes que asistieron a una consulta de flebología por presentar várices tronculares o microvárices y a los cuales se les realizó esclerosis de sus lesiones con polidocanol en forma de espuma sin guía por medio del ultrasonido. Se evaluaron un grupo de variables demográficas y se cuantificó la efectividad, el número y tipo de complicaciones y la satisfacción del paciente a los 30 días de concluido el tratamiento. Resultados: Se logró una efectividad del 82 por ciento con una sola sesión de tratamiento que se elevó al 94 por ciento con dos sesiones. Las principales complicaciones fueron el dolor (33,6 por ciento) y el mapeo (12,9 por ciento) y el 90 por ciento de los pacientes se mostró satisfecho con el tratamiento. Conclusiones: la esclerosis con espuma de los trancos venosos y las microvárices fue efectiva, segura y logró un alto nivel de satisfacción de los pacientes.


Objetive: To verify results obtained from the first 285 patients presenting with sclerosis and lower limbs varix, treated using Polidocanol in foam way, and without ultrasound guide. Methods: A prospective, monocentric and controlled study was carried out including the first 285 patients seen in Phlebology consulting room presenting with truncus and microvarix underwent sclerosis of their lesions usisng Polidocanol in a foam way without ultrasound guide. We assessed a group of demographic variables and also we quantify effectiveness, number and type of complications as wll as the satisfaction of patient after 30 days of treatment. Results: We achieved a 82 percent efectiveness with a single session of treatment, which increased to 94 percent with two sessions. Main complications included pain (33,6 percent) and mapping (12,9 percent), and 90 percent of patients were satisfied with treatment. Conclusions: Sclerosis in a foam way of venous trunks and microvarix was effective, safe and achieves a high level of satisfaction in patients.


Subject(s)
Humans , Adult , Sclerosing Solutions/therapeutic use , Prospective Studies
19.
Rev. argent. coloproctología ; 18(3): 389-479, sept. 2007. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-497615

ABSTRACT

Antecedentes: Varios aspectos de las hemorragias digestivas bajas, especialmente cuando se trata de episodios graves, siguen siendo motivo de discusión. En el área diagnóstica no se cuenta con un método de estudio ideal, ni existe acuerdo en la utilización de un algoritmo determinado. En cuanto a la terapéutica, la preferencia por alguno de los métodos disponibles (endoscópicos, endovasculares o quirúrgicos) varía de acuerdo a la experiencia personal del autor consultado, a la del servicio donde este se desempeña, o a la disponibilidad del procedimiento. La morbilidad es alta y la mortalidad oscila entre el 3 y el 36 por ciento. Objetivo: Realizar una actualización del tema. Discutir los aspectos en controversia, especialmente los relacionados al disgnóstico y la terapéutica. Tratar de exponer a través de los resultados de la encuesta nacional, las preferencias de los especialistas y centros de referencia en la atención de estos pacientes. Presentar nuestra experiencia, conducta y resultados. Pacientes y método: Un total de 1521 casos de hemorragias digestivas bajas fueron admitidos para su internación en el Servicio de Cirugía General y Coloproctología de la Clínica Modelo de Lanús entre enero de 1987 y diciembre de 2006. De las cuales 153 fueron graves y serán la población de estudio de esta presentación. Para este relato realizamos además una encuesta que fue dirigida a los jefes de Servicio de Cirugía General o Coloproctología de Hospitales y Centros Privados de todo el país. Se confeccionaron 15 preguntas cerradas, con una sola posibilidad de respuesta. Analizamos, de los casos de nuestra experiencia y del resultado de la encuesta, los factores relacionados a la utilidad de la clasificación, el género, la etiología más frecuente, la metodología de diagnóstico con mayor rendimiento, el tratamiento, la morbilidad y la mortalidad. Resultados: El 10 por ciento (153) de los pacientes admitidos se clasificaron como cuadros graves. Masculinos el 43.2 por ciento...


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged, 80 and over , Health Surveys , Gastrointestinal Hemorrhage/surgery , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/mortality , Gastrointestinal Hemorrhage/therapy , Acute Disease , Angiography/trends , Congress , Colectomy/methods , Colectomy/trends , Diagnostic Imaging , Endoscopy/methods , Morbidity , Prognosis , Shock, Hemorrhagic/etiology , Shock, Hemorrhagic/therapy , Sclerosing Solutions/therapeutic use
20.
Article in Korean | WPRIM | ID: wpr-82666

ABSTRACT

Duodenal varix is a rare cause of hemorrhage in patients with portal hypertension, however their rupture is serious and often life threatening. Treatments for duodenal variceal bleeding include endoscopic procedures, surgery, or interventional radiologic procedures. We report a case of duodenal varices rupture in a 45-year-old man with alcoholic liver cirrhosis who presented with melena and dizziness. Emergent upper endoscopy revealed large nodular varices with a ruptured erosion on the top in the distal second portion of duodenum. Two consecutive injections with 1.0 mL of n-butyl-2-cyanoacrylate (Histoacryl; Braun-Melsungen, Germany) mixed with 1.0 mL of lipiodol (Laboratoire-Guerbet, France) were performed intravariceally and achieved successful hemostasis. This suggests that endoscopic injection sclerotherapy with histoacryl may be an effective therapeutic option for the control of ruptured duodenal variceal bleeding.


Subject(s)
Duodenal Diseases/etiology , Duodenoscopy , Duodenum/blood supply , Enbucrilate/analogs & derivatives , Gastrointestinal Hemorrhage/etiology , Humans , Liver Cirrhosis, Alcoholic/complications , Male , Middle Aged , Rupture , Sclerosing Solutions/therapeutic use , Sclerotherapy , Tissue Adhesives/therapeutic use , Tomography, X-Ray Computed , Varicose Veins/complications
SELECTION OF CITATIONS
SEARCH DETAIL